INDEGENE
|
The Current P/E Ratio of INDEGENE is 32.56.
Share Price | ₹551.7 | May 09,2025 |
Market Cap | ₹13,240.8 Cr | |
Earnings-TTM | ₹406.7 Cr | TTM-Consolidated Results |
Price/Earnings | 32.56x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INDEGENE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹13,240.8 Cr] as on May 09,2025
(/) Earnings [ ₹406.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 32.56x ]
Thus, for INDEGENE , the investors are currently willing to pay 32.56 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDEGENE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDEGENE over the last five years.
Historical PE (Price/Earnings) ratio chart of INDEGENE
PE Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- INDEGENE 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/e ratio peaked in Mar2024 at 0x.
- INDEGENE 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INDEGENE | 406.70 | 32.56 | 13,240.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.45 | 418,648.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 77.07 | 159,310.0 |
CIPLA LTD | 5,000.43 | 23.88 | 119,410.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.03 | 106,189.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 16.92 | 96,496.4 |
MANKIND PHARMA LTD | 2,050.73 | 48.55 | 99,569.6 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.24 | 88,337.3 |
LUPIN LTD | 2,892.10 | 32.17 | 93,051.6 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.31 | 67,585.0 |
ABBOTT INDIA LTD | 1,334.46 | 48.01 | 64,061.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDEGENE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 16.92x |
Max industry PE | 77.07x |
Median industry PE | 32.56x |
Average industry PE | 37.38x |
You may also like the below Video Courses